TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis

European Journal of Immunology

Volumn 42, Issue 8, 2012, Pages 2087-2099

  Paul, Joydeep ^a   Karmakar, Subir ^a   De, Tripti ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Arginase; IFN IL 10 ratio; Immunoprophylaxis; Parasitic protozoan; Toll like receptor

Indexed keywords

29 KDA BETA 1,4 GALACTOSE TERMINAL GLYCOPROTEIN; ARGINASE 1; GAMMA INTERFERON; GLYCOPROTEIN; IMMUNOGLOBULIN G1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NONHUMAN; PARASITE CLEARANCE; PARASITE VIRULENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODY FORMATION; ARGINASE; DOWN-REGULATION; GLYCOPROTEINS; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; PROTOZOAN PROTEINS; REACTIVE OXYGEN SPECIES; TH1-TH2 BALANCE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864754082     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242428     Document Type: Article

References (50)

1. Olivier, M., Badaro, R., Medrano, F. J. and Moreno, J., The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms. Ann. Trop. Med. Parasitol. 2003. 97 (Suppl 1): 79-98.
2. Russo, R., Laguna, F., Lopez-Velez, R., Medrano, F. J., Rosenthal, E., Cacopardo, C. and Nigro, L. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections. Ann. Trop. Med. Parasitol. 2003. 97 (Suppl 1): 99-105.
3. Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Cañavate, C., Dedet, J. P., Gradoni, L. et al. The relationship between leishmaniasis and AIDS: the second 10 years. Cin. Microbiol. Rev. 2008. 21: 334-359.
4. Kedzierski, L. Leishmaniasis vaccine: where are we today? J. Global Infect. Dis. 2010. 2: 177-185.
5. Schroeder, J. and Aebischer, T. Vaccines for leishmaniasis: from proteome to vaccine candidates. Hum.Vaccin. 2011. 7: 10-15.
6. Beutler, B. A. TLRs and innate immunity. Blood 2009. 113: 1399-1407.
7. Kapsenberg, M. L. Dendritic-cell control of pathogen-derived T-cell polarization. Nat. Rev. Immunol. 2003. 3: 984-993.
8. Goriely, S., Neurath, M. F. and Goldman, M. How microorganisms tip the balance between interleukin-12 family members. Nat. Rev. Immunol. 2008. 8: 81-86.
9. Dissanayake, S. and Shahin, A. Induction of interferon-gamma Induction of interferon-gamma by Taenia crassiceps glycans and Lewis sugars in naive BALB/c spleen and peritoneal exudate cells. Mol. Immunol. 2007. 44: 1623-1630.
10. Bhaumik, S. K., Singh, M., Basu, R., Bhaumik, S., Roychoudhury, K., Naskar, K., Roy, S. et al., Virulence attenuation of a UDP-galactose/N-acetylglucosamine β1, 4 galactosyltransferase expressing Leishmania donovani promastigote. Glycoconjugate J. 2008. 25: 459-472.
11. Franchini, M., Schweizer, M., Matzener, P., Magkouras, I., Sauter, K. S., Mirkovitch, J., Peterhans, E. et al., Evidence for dissociation of TLR mRNA expression and TLR agonist-mediated functions in bovine macrophages. Vet. Immunol. Immunopathol. 2006. 110: 37-49.
12. Werling, D. and Jungi, T. W. Toll-like receptors linking innate and adaptive immune response. Vet. Immunol. Immunopathol. 2003. 91: 1-12.
13. Murray, H. W. and Nathan, C. F. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J. Exp. Med. 1999. 189: 741-746.
14. Re, F. and Strominger, J. L. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J. Immunol. 2004. 173: 7548-7555.
15. Carvalho, E. M., Teixeira, R. S. and Johnson, Jr. W. D. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infect. Immun. 1981. 33: 498-500.
16. Gautam, S., Kumar, R., Maurya, R., Nylen, S., Ansari, N., Rai, M., Sundar, S. et al. IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J. Inf. Dis. 2011. 204: 1134-1137.
17. Silvestre, R., Cordeiro-Da-Silva, A., Santarém, N., Vergnes, B., Sereno, D. and Ouaissi, A. SIR2-deficient Leishmania infantum induces a defined IFN-γ/IL-10 pattern that correlates with protection. J. Immunol. 2007; 179: 3161-3170.
18. Wilson, M. E., Jeronimo, S. M. B. and Pearson. Immunopathogenesis of infection with the visceralizing Leishmania species. Microb. Pathog. 2005. 38: 147-160.
19. Stevens, T. L., Bossie, A., Sanders, V. M., Fernandez-Botran, R., Coffmann, R. L., Mosmann, T. R. and Vitetta, E. S. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature 1988. 334: 255-258.
20. Awasthi, A., Mathur, R. A. and Saha, B. Immune response to Leishmania infection. Ind. J. Med. Res. 2004. 119: 238-258.
21. Kropf, P., Fuentes, J. M., Fahnrich, E., Arpa, L., Herath, S., Weber, V., Soler, G. et al. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 2005. 19: 1000-1002.
22. Biswas, A., Bhattacharya, A., Kar, S. and Das, P.K. Expression of IL-10-triggered STAT3-dependent IL-4Rα is required for induction of arginase 1 in visceral leishmaniasis. Eur. J. Immunol. 2011. 41: 992-1003.
23. Gotoh, T. and Mori, M. Arginase II downregulates nitric oxide (NO) production and prevents NO-mediated apoptosis in murine macrophage-derived RAW 264.7 cells. J. Cell Biol. 1999. 144: 427-433.
24. Cunningham, A. C. Parasitic adaptive mechanisms in infection by Leishmania. Exp. Mol. Pathol. 2005. 72: 132-141.
25. Nylen, S. and Sacks, D. Interleukin-10 and the pathogenesis of visceral leishmaniasis. Trends Immunol. 2007. 28: 378-384.
26. Olivier, M., Gregory, D. and Forget, G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin. Microbiol. Rev. 2005. 18: 293-305.
27. Wanasen, N. and Soong, L. L-arginine metabolism and its impact on host immunity against Leishmania infection. Immunol. Res. 2008. 41: 15-25.
28. Noel, W., Raes, G., Hassanzadeh Ghassabeh, G., De Baetselier, P. and Beschin, A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 2004. 20: 126-133.
29. Iniesta, V., Gomez-Nieto, L. C. and Corraliza, I. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 2001. 193: 777-784.
30. Nathan, C. and Xie, Q, W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 1994. 269: 13725-13728.
31. Das, P., Lahiri, A., Lahiri, A. and Chakravortty, D. Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. Plos Pathog. 2010. 6: e1000899.
32. Iniesta, V., Carcelen, J., Molano, I., Peixoto, P. M., Redondo, E., Parra, P., Mangas, M. et al. Arginase I induction during Leishmania major infection mediates the development of disease. Infect. Immun. 2005. 73: 6085-6090.
33. Raman, V. S., Bhatia, A., Picone, A., Whittle, J., Bailor, H. R., O'Donnell, J., Pattabhi, S. et al. Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis. J. Immunol. 2010. 185: 1701-1710.
34. Srivastava, A., Singh, N., Mishra, M., Kumar, V., Gour, J. K., Bajpai, S., Singh, S. et al. Identification of TLR inducing Th1-responsive Leishmania donovani amastigote-specific antigens. Mol. Cell. Biochem. 2012. 359: 359-368.
35. Kropf, P., Freudenberg, M. A., Modolell, M., Price, H. P., Herath, S., Antoniazi, S., Galanos, C. et al. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 2004.72: 1920-1928.
36. Chandra, D. and Naik, S. Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocyte lineage by modulating MAPK pathways through a contact-dependent mechanism. Cell. Exp. Immunol. 2008. 154: 224-234.
37. Stober, C. B., Lange, U. G., Roberts, M. T., Alcami, A. and Blackwell, J. M. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J. Immunol. 2005. 175: 2517-2524.
38. Nylen, S. and Gautam, S. Immunological perspectives of leishmaniasis. J. Global.Inf. Dis. 2010. 2: 135-146.
39. Selvapandiyan, A., Dey, R., Nylen, S., Duncan, R., Sacks, D. and Nakhasi, H. L. Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis. J. Immunol. 2009. 183: 1813-1820.
40. Alexander, J. and Bryson, K. T helper(h)/Th2 and Leishmania: paradox rather than paradigm. Immunol. Letter. 2005. 99: 17-23.
41. Murray, H. W., Lu, C. M., Mauze, S., Freeman, S., Moreira, A. L., Kaplan, G. and Coffman, R.L. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 2002. 70: 6284-6293.
42. Buxbaum, L. U. and Scott, P. Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Infect. Immun. 2005. 73: 2101-2108.
43. Noben-Trauth, N., Lira, R., Nagase, H., Paul, W. E. and Sacks, D. L. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J. Immunol. 2003. 170: 5152-5158.
44. Kaye, P. M., Svensson, M. A., Maroof, A., Polley, S., Stager, S., Zubairi, S. et al. The immunopathology of experimental visceral leishmaniasis. Immunol. Rev. 2004. 201: 239-253.
45. Bhaumik, S. K., Naskar, K. and De, T. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Eur. J. Immunol. 2009. 39: 2146-2160.
46. De, T. and Roy, S. Infectivity and attenuation of Leishmania donovani promastigotes: association of galactosyl transferase with loss of parasite virulence. J. Parasitol. 1999. 85: 54-59.
47. Karmakar, S., Paul, J. and De, T. Leishmania donovani glycosphingolipid facilitates antigen presentation by inducing relocation of CD1d into lipid rafts in infected macrophages. Eur. J. Immunol. 2011. 41: 1376-1387.
48. Corraliza, I. M., Campo, M. L., Soler, G. and Modelell, M. Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 1994. 174: 231-235.
49. Stauber, L. A. Host resistance to Khartoum strain of Leishmania donovani. Rice Inst. Pamphlet. 1958. 45: 80-83.
50. Rosenthal, H. E. A graphic method for the determination and presentation of binding parameters in a complex system. Anal. Biochem. 1967. 20: 525-532.